These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7675850)

  • 1. Prenatal lorazepam exposure: 4. Persistent alterations in pentylenetetrazole-induced seizure threshold and GABA-dependent chloride uptake after prenatal lorazepam exposure.
    Koff JM; Miller LG
    Pharmacol Biochem Behav; 1995 Aug; 51(4):721-4. PubMed ID: 7675850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent alterations in GABAA receptor binding and function after prenatal lorazepam administration in the chick.
    Miller LG; Roy RB; Weill CL; Lopez F
    Brain Res Bull; 1989 Sep; 23(3):171-4. PubMed ID: 2555030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to benzodiazepine--I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function.
    Chesley S; Lumpkin M; Schatzki A; Galpern WR; Greenblatt DJ; Shader RI; Miller LG
    Neuropharmacology; 1991 Jan; 30(1):53-8. PubMed ID: 1646419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal lorazepam administration is associated with GABAA receptor alterations in late embryonic and mature chicks.
    Miller LG; Weill CL; Roy RB
    Neurotoxicology; 1989; 10(3):517-22. PubMed ID: 2560535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
    Byrnes JJ; Miller LG; Greenblatt DJ; Shader RI
    Psychopharmacology (Berl); 1993; 111(1):91-5. PubMed ID: 7870939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benzodiazepine administration. XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects.
    Byrnes JJ; Miller LG; Perkins K; Greenblatt DJ; Shader RI
    Neuropsychopharmacology; 1993 May; 8(3):267-73. PubMed ID: 8389555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lorazepam tolerance and withdrawal on GABAA receptor operated chloride channels in mice selected for differences in ethanol withdrawal severity.
    Allan AM; Baier LD; Zhang X
    Life Sci; 1992; 51(12):931-43. PubMed ID: 1381457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam attenuates the behavioral effects of dizocilpine.
    Fahey JM; Pritchard GA; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 1999 Jan; 62(1):103-10. PubMed ID: 9972852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and receptor binding changes during chronic lorazepam administration.
    Fahey JM; Pritchard GA; Grassi JM; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 2001; 69(1-2):1-8. PubMed ID: 11420062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of inhibitors of the high affinity GABA uptake on seizure thresholds in mice.
    Frey HH; Popp C; Löscher W
    Neuropharmacology; 1979 Jul; 18(7):581-90. PubMed ID: 492481
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
    Miller LG; Greenblatt DJ; Roy RB; Summer WR; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):177-82. PubMed ID: 2455789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
    Galpern WR; Miller LG; Greenblatt DJ; Shader RI
    Br J Pharmacol; 1990 Dec; 101(4):839-42. PubMed ID: 1964820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.
    Fahey JM; Grassi JM; Reddi JM; Greenblatt DJ
    Pharmacol Biochem Behav; 2006 Jan; 83(1):21-7. PubMed ID: 16439007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    Allan AM; Baier LD; Zhang X
    J Pharmacol Exp Ther; 1992 May; 261(2):395-402. PubMed ID: 1374467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures.
    Okada R; Negishi N; Nagaya H
    Brain Res; 1989 Feb; 480(1-2):383-7. PubMed ID: 2713664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [35S]TBPS binding but not benzodiazepine binding.
    Miller LG; Chesley S; Galpern WR; Greenblatt DJ; Shader RI
    Pharmacol Biochem Behav; 1991 Oct; 40(2):429-32. PubMed ID: 1666676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):131-4. PubMed ID: 7300916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of benzodiazepines but not GABA or muscimol into pars reticulata substantia nigra suppresses pentylenetetrazol seizures.
    Zhang H; Rosenberg HC; Tietz EI
    Brain Res; 1989 May; 488(1-2):73-9. PubMed ID: 2743142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid.
    Iadarola MJ; Gale K
    Science; 1982 Dec; 218(4578):1237-40. PubMed ID: 7146907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.